NCCN News

September 2022

  • NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over Age 40
  • NCCN Shares New Recommendations for Treating Children With Brain Tumors

August 2022

  • NCCN Policy Summit Speakers Say Flexibility in Supporting and Accommodating Cancer Patients and Caregivers Helps Workplaces Thrive

July 2022

  • UICC Announces a New Global Coalition to Increase Access to and the Use of Essential Cancer Medicines in Low- and Lower-Middle-Income Countries
  • NCCN Honors Oncology Leaders Promoting Progress in Cancer Care
  • BostonGene Announces Integration With NCCN Guidelines

June 2022

  • Updated Guidance for COVID-19 Vaccination From NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People
  • New Cancer Information Resources for People of Ukraine From NCCN
  • NCCN Announces Indiana University Melvin and Bren Simon Comprehensive Cancer Center as 32nd Member Institution
  • UT Southwestern’s Dr. John Sweetenham Elected Board Chair for National Comprehensive Cancer Network
  • NCCN Foundation Announces Awards for Rising Cancer Research Leaders

May 2022

  • NCCN Annual Conference Focuses on Cancer Patient Journey; With Cutting-Edge Research and Latest Evidence-Based Care Recommendations
  • Free Guide to Colorectal Cancer Screening From NCCN Now Available in More Than a Dozen Languages
  • NCCN Pharmacy Directors Forum Publishes Recommendations for Safely Dispensing Investigational Medications for Clinical Trials

April 2022

  • NCCN Expands Resources for Treating Rare Cancer Types
  • Nearly 100 Cancer Organizations Urge Congress to Fund Cancer Moonshot Initiatives
  • Reducing Hereditary Cancer Act Promises to Expand Access to Cancer Screenings and Interventions for High-Risk Medicare Beneficiaries